Top Industry Leaders in the Breathing Disorders & Treatment Market
Latest Breathing Disorders Treatment Companies Update:
Philips Healthcare Announced the expansion of their BioTelemetry Platform in January 2024, enabling remote monitoring of a wider range of vital signs and physiological parameters for improved patient care, including breathing difficulties.
ResMed Launched the AirTouch™ F20 Full Face Mask in October 2023, featuring a soft and flexible design for more comfortable sleep apnea therapy.
Masimo Corporation Received FDA approval for their Radius-7 Pulse Oximeter in December 2023, offering continuous monitoring of blood oxygen saturation and pulse rate, helpful for managing breathing disorders.
Propeller Health Partnered with a major health insurance company in February 2024 to provide their Propeller Breathe digital therapeutic app for asthma management to a wider user base.
Air Liquide Announced the development of a next-generation high-flow nasal oxygen therapy (HFNO) device in November 2023, aiming to offer improved comfort and treatment efficacy for respiratory insufficiency.
List of Breathing Disorders Treatment Key companies in the market
- AstraZeneca
- GlaxoSmithKline
- Merck Sharp & Dohme Corp.
- Abbott
- Medtronic plc
- Hoffmann-La Roche Ltd
- Novartis AG
- Reddy’s Laboratories
- Amgen
- Aurobindo Pharma.
- Bayer AG
- Biogen